We are proud to launch our Strategy for 2025–2030. It is a bold and focused plan that aims to strengthen our impact, sharpen our purpose, and reflect the evolving needs of people affected by GI cancer in Australia and Aotearoa New Zealand.
A refined vision and purpose
As part of this new strategy, we have redefined our vision and purpose to better reflect who we are and the future we’re working to create.
- Our vision: A better future for people with GI cancer.
- Our purpose: We bring together a diverse network of brilliant people to deliver clinical trials that improve outcomes for people affected by GI cancers.
This shift moves us from the previously broad ambition of eliminating GI cancer, to a practical and people-centred focus on improving lives now and driving progress through the unique role we play in the cancer research ecosystem.
Our strategic priorities
Over the next five years, we will focus on four key priorities that build on our strengths and position us to lead change where it matters most:
- Set the agenda for collaborative, practice-changing GI cancer clinical trials.
- Strengthen the impact of GI cancer trials across Australia and Aotearoa New Zealand.
- Build capacity for GI cancer trials that are important to our region.
- Mobilise participation of a diverse community of people who share our vision.
To bring our strategy to life, we will focus on delivering clinical trials that answer critical, globally significant questions in GI cancer. Improving equitable access remains central to our work to ensure people can take part in our trials no matter where they live or what language they speak. Our trial coordination services will continue to strengthen and expand as a hub for high-quality, collaborative research.
We will foster partnerships across Australia, Aotearoa New Zealand, and beyond to expand the reach of our work, while building a strong, sustainable foundation through funding, collaboration, and a skilled team. Most importantly, people with lived experience of GI cancer will help shape our research every step of the way.
A consistent thread across all our priorities will be sharing knowledge and insights from our research to deepen engagement with our community and maximise the impact of our trials.
Looking ahead
By 2030, we aim to be recognised as the driving force behind a more connected, capable, and inclusive GI cancer trials ecosystem – shaping clinical practice and delivering real improvements for people affected by GI cancer.